Clinical Trial Update: Sunitinib Malate, Hormone Ablation and Radiation Therapy in Patients With Prostate Cancer [Phase 1]

View source ↗

Summary

A phase 1 clinical trial evaluating Sunitinib Malate in combination with hormone ablation and radiation therapy in patients with prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Sunitinib malate (sunitinib malate)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Prostate Cancer | Phase 1 | Status: COMPLETED